Iovance Biotherapeutics Stock News & Updates
[WKN: A2DT49 | Symbol: IOVA]
Iovance Biotherapeutics
Iovance Biotherapeutics: Amtagvi Boom Drives Forecast!
Iovance Biotherapeutics: Rising Amtagvi demand secures higher target for 2026 - 10% stock jump leads the stock to a 52-week high!
Iovance Biotherapeutics raises its revenue forecast for 2026 to $410 to $420 million. The increase...
Iovance Biotherapeutics: The Pioneer of Personalized Cancer Therapy on the Brink of Breakthrough
Iovance Biotherapeutics has a first-mover advantage, as the company has commercialized Amtagvi, the...
Iovance Biotherapeutics: Amtagvi Grows by 68% – Lung Cancer Opens Seven Times Larger Market Opportunity
Iovance is developing TIL cell therapies for solid tumors and already markets an approved therapy...
Analysts' Top 5 Price Targets of August 07, 2026
Süss MicroTec [DE000A1K0235] Berenberg confirms Buy rating with a price target of 125 Euros (50% upside...
Iovance: Cell Therapy Pioneer Finally Scaling – now the Lung Cancer Market is in Focus
Disappointed expectations caused the Iovance stock price to plummet from $18.33 in March 2024 to $1.64...
- ‹
- 1
- ›